Abstract
Cannabis sativa (hemp) as multifunctional crop have traditional application as fiber, food, paper, textile and pharmaceutical potential as inflorescences and seed as sources of exciting bioactive secondary metabolites. The Genus Cannabis is the only producer of phytocannabinoids. Extensive studied have been made to describe the origin history, geographical ranges and genetic identity of the Cannabis species but it remains obscured to date. Various high through put genetic marker have been studied to assess the genetic diversity in hemp varieties. Studies also indicated that domestication origin affects the genetic groups of hemp which further consequences on the chemical diversity of the cannabis. Chemotaxonomy using chemical markers also played a crucial role in differencing and allocating the Cannabis taxa. Cannabinoids ratio and terpene composition are the major marker to play an important role in studying chemical diversity of Cannabis sp. Cannabis genus is the only source of phytocannabinoids the dominant chemical class. Other than cannabinoids terpene and non-cannabinoid phenolic compounds also contribute in the chemical diversity of the species. The vast array of phytochemicals presents in the genus have potential application in pharmaceutical industries. However, due to its legalization status very limited study on its chemical and genetic diversity have been done. Therefore, the species needs attention to explore its commercial value.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
2.1 Introduction
Cannabis is an erect, annual, dioecious and economically important aromatic medicinal herb belonging to the cannabaceae family (Pellati et al. 2018). The origination of cannabis was believed to be from Central Asia about ~500 BC (Farag and Kayser 2017). Plants belongs to this genus are well grown in wet land sites and near water bodies, where the concentration of nitrogen are found high (Small 2015). Cannabis is highly used and described genus in Ayurveda to provide various pharmacological bioactive compounds and benefits. Now a days, people take interest in this multipurpose plant due to the presence of high content of various nutrients along with bioactive therapeutic compounds having analgesic, anti-spasmodic, anti-tumour, anti-inflammatory, anti-oxidant, antineoplastic, neuro-protective, immunosuppressive, anti-nociceptive, antiepileptic, and anti-depressant properties (Carchman et al. 1976; Ameri et al. 1999; Callaway 2004; Gomes et al. 2008; Appendino et al. 2011) Cannabinoids, the major fundamental phytoconstituent of this genus which are chemically a unique class of terpenophenolic compounds having pharmaceutical potential such as anti0inflammatory, anti-cancer, antimicrobial, anti-arthritic, neuro antioxidative, etc. (De Petrocellis et al., 2011). Apart from this, hemp is also used by the mankind as natural fibres in the textile industry and as seed oil in the cosmetic production (Gautam et al. 2013; Clarke and Merlin 2013; Russo et al. 2008; Farag and Kayser 2017). Hemp use as a suitable eco-friendly option for phyto-remediation and bio fuel production has also been reported (Kumar et al. 2017).
Hemp is a highly variable species in plant system and it has been a matter of debate that whether the genus Cannabis having one species or more than one species (Chandra et al. 2017). According to Hazekamp and Fischedick (2012), Cannabis is a monotypic genus and consists a single species namely Cannabis sativa (described by Leonard Fuchs in the sixteenth century). Approximately 700 different varieties/cultivars of Cannabis have been identified and distinguished by the plant breeders and recreational users due to the results of centuries of breeding and selection. However, it is unclear whether or not these cultivars reflect any relevant differences in chemical composition.
2.2 Varieties of Hemp
With the course of time, different varieties of hemp have been evolved as the result of plant breeding and selection programme. Till so far, no in-dept study on the monospecific or/and polyspecific character of genus Cannabis has been made. According to the (United Nations Office on Drugs and Crime (UNODC) hemp is divided into three different categories like (a) fiber hemp (b) oil seed hemp and (c) drug hemp (Farag and Kayser 2017). Similarly, Schultes et al. (1974) also differentiated this genus into three species such as C. sativa L., C. indica L., and C. ruderalis. However, many reports are available on Cannabis is monotypic genus that consist only a single species C. sativa (Beutler and Dermarderosian 1978; Hoffmann 1961). Small and Cronquist (1976) divided the monotypic species C. sativa into the subspecies ‘sativa’ and ‘indica’ each with two different variants i.e., domesticated (C. sativa subsp. sativa var. sativa and C. sativa subsp. indica var. indica) and wild varieties (C. sativa subsp. sativa var. spontama and C. sativa subsp. indica var. kafiristanica). In last two decades, various new hybrid varieties have been also developed like ‘Super-sativa’, ‘Bedrocan’, ‘Bedrobinol’, and ‘Bediol’ etc. (Clarke and Watson 2002; de Meijer 2004; Flemming et al. 2007). Many Cannabis hybrid varieties and some pure strains have been now commercialized by many private farms and ~20 strains are well defined for the cultivation of Hemp. A large number of plant breeders cultivate fiber hemp variety with the target to reduce THC concentration (de Meijer 1995). During the origination process of plant, particularly Hemp opened the path to hybridization and leads the development of thousands of cultivars. Small (2015) stated that there is a serious taxonomic issue to classify the different strains of Cannabis and divide the C. sativa L. species into 3 subspecies or variants such as ‘sativa’ (industrial cannabis/hemp having a limited amount of tetrahydrocannabinol or THC), ‘indica’ (medicinal cannabis/marijuana producing principally THC), and ‘ruderalis’ (known for wild hemp strains). Clarke and Merlin (2016) referred C. ruderalis as ancestor of two modern Cannabis sp. (C. sativa and C. indica), originated from central Asia. The recent taxonomy of Cannabis was given by Clarke and Merlin (2016) as presented in Fig. 2.1.
2.3 Geographical Distribution
Cannabis has usually a wide range of geographical and ecological distribution. It is grown worldwide except Antarctica, in a broad range of environment from sub-arctic to temperate and tropical from sea level to over 3000 m elevation (Clarke and Merlin 2013; Glanzman 2015). This genus is believed to have originated in the Northwest Himalayas and widely distributed in the range of Africa. Small and Cronquist (1976) reported that genus Cannabis, geographically distributed towards latitude 30°N (North) and 60°N (South) (Hillig 2005).
Clarke and Merlin (2013), reported that Cannabis is distributed worldwide by humans for multiple purposes. According to the authors, the putative ancestor of Cannabis is originated in Central Asia. It is hypothesized that Cannabis distributed into new geographical areas and evolved into 4 taxonomic groups along with gene pools as Cannabis sativa narrow leaflet hemp (NLH), C. indica broad leaflet hemp (BLH), C. indica narrow leaflet drug (NLD), Cannabis indica spp. afghanica broad leaflet drug (BLD). Based on the broad taxonomic groups the worldwide distribution of Cannabis is given in Fig. 2.2.
2.4 Genetic Diversity
Identification of functional gene variation and trait mapping is important step for understanding toward the evolutionary and functional aspects of Cannabis. Hemp possesses diploid genome (2n = 20) with difference in sizes as 818 Mb for female and 843 Mb for males (Sakamoto et al. 1998). Inspite of being restricted due to legalization stautus various authors attempted to study the hemp genetic for various traits like fiber quality, sex determination, sex expression, assessment of population diversity, and genetic relatedness between strains using various genetic tools etc. The genomic markers used for various trait mapping in hemp species are described in Table 2.1.
Various issues regarding naming, breeding and quality control arises in hemp varieties cultivation. According to Lynch et al. (2016) and Schwabe et al. (2019) traditional classification did not determine the genetic relationship in drug-type and fibre-type Cannabis species i.e., ‘indica’ and ‘sativa’. Both drug-type and fiber-type C. sativa plants are genetically different and have been used for breeding practices for various purposes (van Bakel et al. 2011; Sawler et al. 2015; Lynch et al. 2016; Vergara et al. 2021). Previous studies usually focused on Cannabis species having high CBD/low THC but sometime these are closely related to marijuana species (Grassa et al. 2021). However, both types have been practicing to bred for specific compound production like cannabinoids and terpenoids. Cannabis genetics evolving with focus on C. sativa marijuana-type as compared to CBD-type hemp (Lynch et al. 2016; Vergara et al. 2021, Johnson and Wallace 2021).
2.5 Chemical Diversity in Cannabis Sativa
Apart from being controversial crop for various issues related to taxonomic status, origin, morphological and ecological diversity, Cannabis exhibited extensive phytochemical diversity in particular reference to cannabinoid and terpenoid (Hillig and Mahlberg 2004). Phytocannabinoids are the dominant chemical class of genus Cannabis. Cannabinoids are terpenophenolic compounds which are chemically associated terpenes with its ring structure derived from C10 monoterpene subunit i.e., geranyl pyrophosphate. Geranyl pyrophosphate are the biogenetic origin of cannabinoids (Hanus et al. 2016). Two independent pathways namely cytosolic mevalonate and plastidial methylerythritol phosphate (MEP) are responsible for phytoterpene biosynthesis. MEP pathway is reported for the biosynthesis of the cannabinoid terpenoid moiety biosynthesis (Sirikantaramas et al. 2007; ElSohly et al. 2017). The cannabinoids accumulated in cannabis plant as cannabinoid acids and non-enzymatically decarboxylated into their neutral forms during storage (Small 2015). Radwan et al. (2021) reviewed the phytochemistry, isolation, identification and structural elucidation of more than 500 constituents including cannabinoids and non-cannabinoids class of C. sativa. To date different secondary metabolites class of C. sativa were presented in Table 2.2. The chemical structures of cannabinoids and terpenoids compounds are presented in Figs. 2.3 and 2.4.
2.6 Chemotaxonomic Classification of Hemp
Chemotaxonomy/chemosystematics is used to classify according to confirmable differences and similarities in their biochemical compositions. According to Small (1979a) amount of THC in Cannabis is essential for taxonomic characterization. Gas chromatography-flame ionization detection (GC-FID) is commonly used techniques to differentiate indica strains from sativa strains on the basis of THC content (Small and Beckstead 1973a, Small et al. 1975; Small and Cronquist 1976). Numerous phytochemical markers used for chemotaxonomic classification of Cannabis species/varieties are presented in Table 2.3. Based on the quantitative difference in the cannabinoids ratio of tetrahydrocannabinol acid (THC), cannabinol (CBN) and cannabidiol (CBD), in the ratio of (THC) + (CBD)/(CBN) C. sativa classified in three different chemical phenotypes. If THC/CBD > 1 phenotype I (drug- type), THC/CBD = 1 phenotype II (intermediate type) THC/CBD < 1 phenotype III (fibre- type or hemp) (de Meijer et al. 2003; De Backer et al. 2009; Galal et al. 2009).
Health benefits associated to cannabinoids and non-cannabinoids have been presented in Table 2.4. The biological properties related to cannabinoids mainly associated with human endocannabinoid system. The system consists of two G-protein coupled receptors i.e., CB1 and CB2 along with two ligands. The system mainly thought to regulatory role in various physiological processes including pain-sensation, mood, apatite, memory, inflammation and metabolic pathways. CB1 receptors also present on cells of gastrointestinal, adrenal, lung, heart and immune systems however, CB2 receptors exerted immunomodulary effect (Andre et al. 2016). Similarly, terpenes and phenolic compounds linked to Cannabis sp. possesses various biological activities (Table 2.4).
2.7 Conclusion and Future Prospects
Despite of being controversial status of genus Cannabis, it is cultivated worldwide for its high pharmaceutical and industrial potential. Although, chemotaxonomy plays an important role to differentiate various varieties of hemp, but, the origination history and genetic diversity of Cannabis species still remain largely unexplored. As identification of elite chemotype is essential for production of cannabinoid for industrial use, it is paramount to first study genetic and chemical diversity of the plant in details. Considering high medicinal value of Indian varieties, it is essential for the scientific community to start working on this important medicinal agriculture crop. This will not only facilitate in drug discovery programme but can be proved as a boon for the marginal communities of the Himalayan region where this plant is growing as a weed.
References
Ameri A, Wilhelm A, Simmet T (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126(8):1831–1841
Andre CM, Hausman JF, Guerriero G (2016) Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci 7:19
Andre CM, Larondelle Y, Evers D (2010) Dietary antioxidants and oxidative stress from a human and plant perspective: a review. Curr Nutr Food Sci 6:2–12
Appendino G, Chianese G, Taglialatela-Scafati O (2011) Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem 18(7):1085–1099
Beutler JA, Der Marderosian AH (1978) Chemotaxonomy of Cannabis. L crossbreeding between Cannabis sativa and Cannabis ruderalis, with analysis of cannabinoid content. Econ Bot 32(4):287–394
Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D (2013) Beneficial effect of the non-psychotropic plant cannabinoid cannabigerolon experimental in flammatory bowel disease. Biochem Pharmacol 85:1306–1316
Burstein S (2015) Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorg Med Chem 23:1377–1385
Callaway JC (2004) Hempseed as a nutritional resource: an overview. Euphytica 140(1):65–72
Carchman RA, Harris LS, Munson AE (1976) The inhibition of DNA synthesis by cannabinoids. Cancer Res 36(1):95–100
Chandra S, Lata H, Khan IA, ElSohly MA (2017) Cannabis sativa L.: botany and horticulture. In: Chandra S, Lata H, ElSohly M (eds) Cannabis sativa L.-Botany and Biotechnology Springer, Cham, pp 79–100
Clarke R, Merlin M (2013) Introduction to the multipurpose plant Cannabis. In: Cannabis University of California Press, pp 1–12
Clarke RC, Merlin MD (2016) Cannabis Taxonomy: the ‘sativa’ vs ‘indica’ Debate. Herbal Gram 110:44–49
Clarke RC, Watson DP (2002) Botany of natural Cannabis medicines. In: Grotenhermen F, Russo E (eds) Cannabis and cannabinoids: pharmacology, toxicology and therapeutic potential, The Haworth Integrative Healing Press, pp 3–13
Cleemput MV, Cattoor K, Bosscher KD, Haegeman G, Keukeleire DD, Heyerick A (2009) Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds. J Nat Prod 72:1220–1230
Conneely LJ, Mauleon R, Mieog J, Barkla BJ, Kretzschmar T (2021) Characterization of the Cannabis sativa glandular trichome proteome. PLoS ONE 16(4):e0242633
Cui-Ying M, Wing Keung L, Chun-Tao C (2002) Lignanamides and nonalkaloidal components of Hyoscyamus niger seeds. J Nat Prod 65:206–209
Datwyler SL, Weiblen GD (2006) Genetic variation in hemp and marijuana (Cannabis sativa L.) according to amplified fragment length polymorphisms. J Forensic Sci 51(2):371–375
Davis WM, Hatoum NS (1983) Neuro behavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol. Gen Pharmacol Vasc Sys 14:247–252
De Backer B, Debrus B, Lebrun P, Theunis L, Dubois N, Decock L et al (2009) Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J Chromatogr B 877(32):4115–4124
de Meijer E (2004) The breeding of cannabis cultivars for pharmaceutical end uses. Medicinal uses of Cannabis and Cannabinoids. Pharm Press, London, pp 55–70
De Meijer EP, Bagatta M, Carboni A, Crucitti P, Moliterni VC, Ranalli P et al (2003) The inheritance of chemical phenotype in Cannabis sativa L. Genetics 163(1):335–346
de Meijer EPM (1995) Fibre hemp cultivars: a survey of origin, ancestry, availability and brief agronomic characteristics. J Int Hemp 2(2):66–73
De Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S (2011) Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163:1479–1494
DeLong GT, Wolf CE, Poklis A, Lichtman AH (2010) Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by _9-tetrahydrocannabinol. Drug Alcohol Depend 112:126–133
Dufresnes C, Jan C, Bienert F, Goudet J, Fumagalli L (2017) Broad-scale genetic diversity of Cannabis for forensic applications. PLoS ONE 12(1):e0170522
Eisohly HN, Turner CE, Clark AM, Eisohly MA (1982) Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds. J Pharm Sci 71:1319–1323
ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A (2017) Phytochemistry of Cannabis sativa L. Phytocannabinoids 1–36
ElSohly MA, Slade, D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78(5):539–548
Elzinga S, Fischedick J, Podkolinski R, Raber JC (2015) Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Nat Prod Chem Res 3(81):10–4172
Faeti V, Mandolino G, Ranalli P (1996) Genetic diversity of Cannabis sativa germplasm based on RAPD markers. Plant Breed 115(5):367–370
Farag S, Kayser O (2017) The Cannabis plant: botanical aspects. In: Handbook of Cannabis and Related Pathologies Academic Press, pp 3–12
Faux AM, Draye X, Flamand MC, Occre A, Bertin P (2016) Identification of QTLs for sex expression in dioecious and monoecious hemp (Cannabis sativa L.). Euphytica 209(2):357–376
Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R (2010) Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 71(17–18):2058–2073
Flemming T, Muntendam R, Steup C, Kayser O (2007) Chemistry and biological activity of tetrahydrocannabinol and its derivatives. In: Bioactive Heterocycles IV. Springer, Berlin, Heidelberg, pp 1–42
Galal AM, Slade D, Gul W, El-Alfy AT, Ferreira D, ElSohly MA (2009) Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications. Recent Pat CNS Drug Discov 4:112
Gautam AK, Kant M, Thakur Y (2013) Isolation of endophytic fungi from Cannabis sativa and study their antifungal potential. Arch Phytopathol Pflanzenschutz 46(6):627–635
Gilmore S, Peakall R, Robertson J (2007) Organelle DNA haplotypes reflect crop-use characteristics and geographic origins of Cannabis sativa. Forensic Sci Int (2–3):179–190
Glanzman A (2015). Discover Himalaya’s Outlawed Marijuana fields. Time. http://time.com/3736616/discover-himalayas-illegal-marijuana-fields/. Accessed 24 Nov 2021
Gomes A, Fernandes E, Lima JL, Mira L, Corvo ML (2008) Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem 15(16):1586–1605
Grassa CJ, Weiblen GD, Wenger JP, Dabney C, Poplawski SG, Timothy Motley S et al (2021) A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana. New Phyto 230(4):1665–1679
Hakki EE, Kayis SA, Pinarkara E, Sag A (2007) Inter simple sequence repeats separate efficiently hemp from marijuana (Cannabis sativa L.). Electro J Biotechnol 10(4):570–581
Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G (2016) Phytocannabinoids: a unified critical inventory. Nat Prod Rep 33(12):1357–1392
Hazekamp A, Fischedick JT (2012) Cannabis—from cultivar to chemovar. Drug Test Anal (Nov 2011):660–667
Hazekamp A, Tejkalová K, Papadimitriou S (2016) Cannabis: from cultivar to chemovar II—a metabolomics approach to Cannabis classification. Cannabis Cannabinoid Res 1(1):202–215
Henry P, Khatodia S, Kapoor K, Gonzales B, Middleton A, Hong K et al (2020) A single nucleotide polymorphism assay sheds light on the extent and distribution of genetic diversity, population structure and functional basis of key traits in cultivated north American Cannabis. J Cannabis Res 2(1):1–11
Hillig KW (2005) Genetic evidence for speciation in Cannabis (Cannabaceae). Genet Resour Crop Evol 52(2):161–180
Hillig KW, Mahlberg PG (2004) A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). Am J Bot 91(6):966–975
Hoffmann W (1961) Hanf, Cannabis sativa. In: Kappert H, Rudorf W(Eds.) Handbuch der Pflanzenzüchtung, Band V. Paul Parey, Berlin-Hamburg, pp 204–261
Hu ZG, Guo HY, Hu XL, Chen X, Liu XY et al (2012) Genetic diversity research of hemp (Cannabis sativa L) cultivar based on AFLP analysis. J Plant Genet Resour 13(4):555–561
Jenkins C, Orsburn B (2020) The Cannabis Proteome draft map project. Int J Mol Sci 21:965
Jin D, Henry P, Shan J, Chen J (2021) Identification of chemotypic markers in three chemotype categories of cannabis using secondary metabolites profiled in inflorescences, leaves, stem bark, and roots. Front Plant Sci 12
Johnson MS, Wallace JG (2021) Genomic and chemical diversity of commercially available industrial hemp accessions. bioRxiv
Komori T, Fujiwara R, Tanida M, Nomura J, Yokoyama MM (1995) Effects of citrus fragrance on immune function and depressive states. Neuroimmunology 2:174–180
Kumar S, Singh R, Chandra V, Rani A, Jain R (2017) Cannabis sativa: a plant suitable for phytoremediation and bioenergy production. In: Bauddh K, Singh B, Korstad J (eds) Phytoremediation potential of bioenergy plants. Springer, Singapore, pp 269–285
Laverty KU, Stout JM, Sullivan MJ, Shah H, Gill N, Holbrook L, Deikus G, Sebra R, Hughes TR, Page JE, Van Bakel H (2019) A physical and genetic map of Cannabis sativa identifies extensive rearrangements at the THC/CBD acid synthase loci. Genome res 29(1):146–156
Lynch RC, Vergara D, Tittes S, White K, Schwartz CJ, Gibbs MJ et al (2016) Genomic and chemical diversity in Cannabis. Crit Rev Plant Sci 35(5–6):349–363
Mechoulam R (2005) Plant cannabinoids: a neglected pharmacological treasure trove. Br J Pharmacol 146(7):913–915
Moses T, Pollier J, Thevelein JM, Goossens A (2013) Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro. New Phytol 200:27–43
Pavlovic R, Panseri S, Giupponi L, Leoni V, Citti C, et al (2019) Phytochemical and ecological analysis of two varieties of hemp (Cannabis sativa L.) grown in a mountain environment of Italian Alps. Front Plant Sci 10:1265
Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L (2018) Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. Biomed Res Int. 1–15
Punja ZK, Rodriguez G, Chen S (2017) Assessing genetic diversity in Cannabis sativa using molecular approaches. In: Cannabis sativa L.-Botany and biotechnology. Springer, Cham, pp 395–418
Radwan MM, Chandra S, Gul S, ElSohly MA (2021) Cannabinoids, phenolics, terpenes and alkaloids of Cannabis. Molecules 26(9):2774
Radwan MM, Ross SA, Slade D, Ahmed SA, Zulfiqar F, ElSohly MA (2008) Isolation and characterization of new Cannabis constituents from a high potency variety. Planta Med 74(03):267–272
Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 163(7):1344–1364
Russo EB, Jiang HE, Li X, Sutton A, Carboni A, Del Bianco F et al (2008) Phytochemical and genetic analyses of ancient cannabis from Central Asia. J Exp Bot 59(15):4171–4182
Sakamoto K, Akiyama Y, Fukui K, Kamada H, Satoh S (1998) Characterization; genome sizes and morphology of sex chromosomes in hemp (Cannabis sativa L.). Cytologia 63(4):459–464
Sawler J, Stout JM, Gardner KM, Hudson D, Vidmar J, Butler L et al (2015) The genetic structure of marijuana and hemp. PLoS ONE 10(8):0133292
Schultes RE, Klein WM, Plowman T, Lockwood TE (1974) Cannabis: an example of taxonomic neglect. Harvard Univ Bot Mus Leafl 23:337–367
Schwabe AL, Mc Glaughlin ME (2019) Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. J Cannabis Res 1(1):1–16
Shoyama Y, Kuboe K, Nishioka I, Yamauchi T (1972) Cannabidiol monomethyl ether. A new neutral cannabinoid. Chem Pharm Bull 20: 2072
Singh B, Sharma R (2015) Plantterpenes: defense responses, phylogenetic analysis, regulation and clinical applications. 3 Biotechnol 5:129–151
Sirikantaramas S, Taura F, Morimoto S, Shoyama Y (2007) Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology. Curr Pharm Biotechnol 8:237
Small E (2015) Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Bot Rev 81(3):189–294
Small E (1979a) The species problem in Cannabis: science and semantics. vol 1: science. Corpus, Toronto
Small E, Beckstead HD (1973) Common cannabinoid phenotypes in 350 stocks of Cannabis. Lloydia 36:144–165
Small E, Beckstead HD, Chan A (1975) The evolution of cannabinoid phenotypes in Cannabis. Econ Bot 219–232
Small E, Cronquist A (1976) A practical and natural taxonomy for Cannabis. Taxon 405–435
Soorni A, Fatahi R, Haak DC, Salami SA, Bombarely A (2017) Assessment of genetic diversity and population structure in Iranian cannabis germplasm. Sci Rep 7(1):1–10
Sun J, Gu YF, Su XQ, Li MM, Huo HX, Zhang J et al (2014) Anti-inflammatory lignanamides from the roots of Solanum melongena L. Fitoterapia 98:110–116
van Bakel H, Stout JM, Cote AG, Tallon CM, Sharpe AG, Hughes TR et al (2011) The draft genome and transcriptome of Cannabis sativa. Genome Biol 12:R102
van den Broeck HC, Maliepaard C, Ebskamp MJM, Toonen MAJ, Koops AJ (2008) Differential expression of genes involved in C1 metabolism and lignin biosynthesis in wooden core and bast tissues of fibre hemp (Cannabis sativa L.). Plant Sci 174:205–220
Vázquez LH, Palazon J, Navarro-Ocaña A (2012) The pentacyclic triterpenes α-, β-amyrins: a review of sources and biological activities. Phytochemicals 23:487–502
Vergara D, Feathers C, Huscher EL, Holmes B, Haas JA, Kane NC (2021) Widely assumed phenotypic associations in Cannabis sativa lack a shared genetic basis. PeerJ 9, p.e10672
Wang C, Kurzer MS (1998) Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nut Cancer 31:90–100
Weiblen GD, Wenger JP, Craft KJ, ElSohly MA, Mehmedic Z, Treiber EL et al (2015) Gene duplication and divergence affecting drug content in Cannabis sativa. New Phytol 208:1241–1250
Werz O, Seegers J, Schaible AM, Weinigel C, Barz D, Koeberle A, Allegrone G, Pollastro F, Zampieri L, Grassi G, Appendino G (2014) Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. PharmaNutrition 2(3):53–60
Zhang J, Yan J, Huang S, Pan G, Chang L, Li J, et al (2020) Genetic diversity and population structure of cannabis based on the genome-wide development of simple sequence repeat markers. Front Genet 11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mishra, V., Dasila, K., Singh, M., Tripathi, D. (2022). Hemp Varieties: Genetic and Chemical Diversity. In: Belwal, T., Belwal, N.C. (eds) Revolutionizing the Potential of Hemp and Its Products in Changing the Global Economy. Springer, Cham. https://doi.org/10.1007/978-3-031-05144-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-05144-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-05143-2
Online ISBN: 978-3-031-05144-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)